Arcellx to participate at the td cowen 45th annual health care conference

Redwood city, calif.--(business wire)--arcellx, inc. (nasdaq: aclx), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the td cowen 45th annual health care conference on wednesday, march 5, at 1:10 p.m. et. a live webcast of this discussion will be accessible from arcellx's website at www.arcellx.com in the investors s.
ACLX Ratings Summary
Quant
ACLX Quant Ranking
Sector
Industry
Quant Rating
Quant Score